chr1-113898739-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001253852.3(AP4B1):c.1177C>T(p.Arg393*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,609,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R393R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001253852.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4B1 | NM_001253852.3 | c.1177C>T | p.Arg393* | stop_gained | 6/10 | ENST00000369569.6 | NP_001240781.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4B1 | ENST00000369569.6 | c.1177C>T | p.Arg393* | stop_gained | 6/10 | 1 | NM_001253852.3 | ENSP00000358582.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151968Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 247150Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133902
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457520Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 725260
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74222
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 47 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Paris Brain Institute, Inserm - ICM | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Oct 11, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 16, 2023 | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Arg393*) in the AP4B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP4B1 are known to be pathogenic (PMID: 22290197, 24700674, 24781758). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia (PMID: 32979048). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 539527). - |
Pathogenic, criteria provided, single submitter | clinical testing | DASA | Nov 03, 2022 | The c.1177C>T;p.(Arg393*) variant creates a premature translational stop signal in the AP4B1 gene. It is expected to result in an absent or disrupted protein product - PVS1. ClinVar contains an entry for this variant (ClinVar ID: 539527) - PS4_supporting. The variant is present at low allele frequencies population databases (rs374894037 – gnomAD 0.0003948%; ABraOM 0.000427 frequency - https://abraom.ib.usp.br/) - PM2_supporting. In summary, the currently available evidence indicates that the variant is pathogenic. - |
Spastic paraplegia Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Oct 01, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at